Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Titel:
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Auteur:
Fedoriw, Andrew Rajapurkar, Satyajit R. O'Brien, Shane Gerhart, Sarah V. Mitchell, Lorna H. Adams, Nicholas D. Rioux, Nathalie Lingaraj, Trupti Ribich, Scott A. Pappalardi, Melissa B. Shah, Niyant Laraio, Jenny Liu, Yan Butticello, Michael Carpenter, Chris L. Creasy, Caretha Korenchuk, Susan McCabe, Michael T. McHugh, Charles F. Nagarajan, Raman Wagner, Craig Zappacosta, Francesca Annan, Roland Concha, Nestor O. Thomas, Roberta A. Hart, Timothy K. Smith, Jesse J. Copeland, Robert A. Moyer, Mikel P. Campbell, John Stickland, Kim Mills, James Jacques-O’Hagan, Suzanne Allain, Christina Johnston, Danielle Raimondi, Alejandra Porter Scott, Margaret Waters, Nigel Swinger, Kerren Boriack-Sjodin, Ann Riera, Tom Shapiro, Gideon Chesworth, Richard Prinjha, Rabinder K. Kruger, Ryan G. Barbash, Olena Mohammad, Helai P.